Latest Breaking News On - குழு இல் நோவர்த்திச் - Page 1 : comparemela.com
Rafael Holdings Appoints Three Highly Experienced Biopharmaceutical Leaders to its Board of Directors
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
NuCana Appoints Andrew Kay as Board Chairman
marketwatch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketwatch.com Daily Mail and Mail on Sunday newspapers.
NuCana Appoints Andrew Kay as Board Chairman
Pharmaceutical Executive Brings a Wealth of Experience to NuCana’s Board of Directors
Previously Served as CEO of Algeta, Chairman of Wilson Therapeutics and Chairman of KaNDy Therapeutics
EDINBURGH, United Kingdom, Dec. 21, 2020 (GLOBE NEWSWIRE) NuCana plc, a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer, announced the appointment of Andrew Kay as Chairman of its Board of Directors.
“We are delighted to welcome Andrew as NuCana’s Board Chairman,” said Hugh S. Griffith, NuCana’s Founder and Chief Executive Officer. “Andrew is an internationally recognized executive and brings a wealth of leadership experience at several successful biotechnology and pharmaceutical companies. His track record of building shareholder value throughout his career, along with his experience taking compounds through development and commercialization will bring significan
NuCana plc: NuCana Appoints Andrew Kay as Board Chairman
Previously Served as CEO of Algeta, Chairman of Wilson Therapeutics and Chairman of KaNDy Therapeutics
EDINBURGH, United Kingdom, Dec. 21, 2020 (GLOBE NEWSWIRE) NuCana plc, a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer, announced the appointment of Andrew Kay as Chairman of its Board of Directors. We are delighted to welcome Andrew as NuCana s Board Chairman, said Hugh S. Griffith, NuCana s Founder and Chief Executive Officer. Andrew is an internationally recognized executive and brings a wealth of leadership experience at several successful biotechnology and pharmaceutical companies. His track record of building shareholder value throughout his career, along with his experience taking compounds through development and commercialization will bring significant value to NuCana. We look forward to working with Andrew as we advance our ProTide pip